1. Home
  2. Share Market
  3. Stocks
  4. Zydus Lifesciences
  5. Financial Statements
  6. Key Financial Ratios

ZYDUSLIFE Financial Statements

Zydus Lifesciences Key Financial Ratios

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 5.96 19.70 27 (0.50)
Op profit growth 20 (2.30) 49.50 (18)
EBIT growth 20.60 (9.10) 45.90 (23)
Net profit growth 81.30 (34) 19.40 (23)
Profitability ratios (%)        
OPM 22.10 19.50 23.90 20.30
EBIT margin 17.60 15.40 20.30 17.70
Net profit margin 14.10 8.26 14.90 15.90
RoCE 13.10 12.10 16.20 14.90
RoNW 4.57 3.08 5.65 5.88
RoA 2.63 1.61 2.97 3.33
Per share ratios ()        
EPS 20.90 11.50 17.10 14.50
Dividend per share 3.50 3.50 3.50 3.20
Cash EPS 13.80 4.69 12.10 10.90
Book value per share 127 101 85.40 68
Valuation ratios        
P/E 21.10 23.30 22.20 30.60
P/CEPS 32 57 31.30 40.70
P/B 3.47 2.64 4.43 6.52
EV/EBIDTA 14.50 11.90 14.50 24.10
Payout (%)        
Dividend payout -- -- 20.20 22
Tax payout (5.90) (17) (24) (8)
Liquidity ratios        
Debtor days 82.10 88 84.10 78.30
Inventory days 72.80 66.30 64.20 61.10
Creditor days (70) (66) (73) (73)
Leverage ratios        
Interest coverage (16) (6.40) (27) (37)
Net debt / equity 0.28 0.68 0.47 0.53
Net debt / op. profit 1.11 2.52 1.44 1.92
Cost breakup ()        
Material costs (34) (35) (35) (36)
Employee costs (16) (17) (16) (16)
Other costs (27) (29) (26) (27)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 15,102 14,253 11,905 9,377
yoy growth (%) 5.96 19.70 27 (0.50)
Raw materials (5,210) (4,920) (4,122) (3,419)
As % of sales 34.50 34.50 34.60 36.50
Employee costs (2,490) (2,415) (1,855) (1,520)
As % of sales 16.50 16.90 15.60 16.20
Other costs (4,061) (4,135) (3,081) (2,533)
As % of sales 26.90 29 25.90 27
Operating profit 3,341 2,783 2,848 1,904
OPM 22.10 19.50 23.90 20.30
Depreciation (725) (697) (539) (373)
Interest expense (164) (342) (91) (45)
Other income 37.20 114 113 128
Profit before tax 2,490 1,859 2,331 1,615
Taxes (147) (320) (564) (129)
Tax rate (5.90) (17) (24) (8)
Minorities and other (4) 1 9.40 2
Adj. profit 2,339 1,540 1,776 1,488
Exceptional items (205) (364) -- (0.30)
Net profit 2,134 1,177 1,776 1,488
yoy growth (%) 81.30 (34) 19.40 (23)
NPM 14.10 8.26 14.90 15.90
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 2,490 1,859 2,331 1,615
Depreciation (725) (697) (539) (373)
Tax paid (147) (320) (564) (129)
Working capital 3,592 3,420 2,804 1,509
Other operating items -- -- -- --
Operating cashflow 5,210 4,262 4,031 2,621
Capital expenditure 14,543 12,749 4,973 3,439
Free cash flow 19,753 17,012 9,004 6,060
Equity raised 12,825 11,580 10,067 9,034
Investments 809 741 631 348
Debt financing/disposal 4,076 7,666 5,098 5,364
Dividends paid -- -- 358 328
Other items -- -- -- --
Net in cash 37,463 36,999 25,158 21,134
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 102 102 102 102
Preference capital -- -- -- --
Reserves 12,890 10,273 10,284 8,642
Net worth 12,992 10,376 10,386 8,745
Minority interest
Debt 4,584 7,986 7,899 5,407
Deferred tax liabilities (net) 671 673 1,058 1,732
Total liabilities 20,184 20,370 20,636 16,074
Fixed assets 12,916 12,972 13,001 8,010
Intangible assets
Investments 830 765 674 746
Deferred tax asset (net) 1,626 1,316 1,776 2,374
Net working capital 3,924 4,352 4,637 3,629
Inventories 3,236 2,789 2,688 2,385
Inventory Days 78.20 71.40 -- 73.10
Sundry debtors 3,127 3,663 3,951 3,206
Debtor days 75.60 93.80 -- 98.30
Other current assets 1,812 1,680 1,651 1,479
Sundry creditors (2,330) (2,162) (2,002) (1,967)
Creditor days 56.30 55.40 -- 60.30
Other current liabilities (1,922) (1,618) (1,651) (1,474)
Cash 888 965 549 1,315
Total assets 20,184 20,370 20,636 16,074
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Dec-2021 Sep-2021 Jun-2021 Mar-2021 Dec-2020
Gross Sales 3,544 3,687 3,917 3,602 3,592
Excise Duty -- -- -- -- --
Net Sales 3,544 3,687 3,917 3,602 3,592
Other Operating Income 111 97.80 108 90.10 41.50
Other Income 60.80 2,549 54 (3.70) 53.80
Total Income 3,716 6,334 4,079 3,689 3,687
Total Expenditure ** 2,903 3,020 3,092 2,960 2,867
PBIDT 813 3,315 987 729 820
Interest 31.10 30.10 27.30 23.20 27.10
PBDT 782 3,284 960 705 793
Depreciation 183 185 183 185 176
Minority Interest Before NP -- -- -- -- --
Tax 51.10 145 128 115 109
Deferred Tax 59.60 (45) 13.40 (326) (4)
Reported Profit After Tax 488 3,000 636 732 513
Minority Interest After NP 10.20 9.60 55.30 56.40 0.80
Net Profit after Minority Interest 500 3,002 587 679 527
Extra-ordinary Items -- (73) -- (56) --
Adjusted Profit After Extra-ordinary item 500 3,075 587 735 527
EPS (Unit Curr.) 4.89 29.30 5.74 6.63 5.15
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 102 102 102 102 102
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 22.90 89.90 25.20 20.20 22.80
PBDTM(%) 22.10 89.10 24.50 19.60 22.10
PATM(%) 13.80 81.40 16.20 20.30 14.30

QuickLinks for Zydus Lifesciences Ltd.

ZYDUSLIFE News

ZYDUSLIFE Information

ZYDUSLIFE Financials

ZYDUSLIFE Documents

Open ZERO Brokerage Demat Account
Open Demat Account

  • ₹0

    Per Order for ETF & Mutual Funds Brokerage

  • ₹20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity